APA (7th ed.) Citation

Petersen, R. C., Graf, A., Atkins, A. S., Brys, M., Murphy, J., Miller, D. S., . . . Weber, C. J. (2025). Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease. Alzheimer's & dementia : translational research & clinical interventions, 11(2), e70069-n/a. https://doi.org/10.1002/trc2.70069

Chicago Style (17th ed.) Citation

Petersen, Ronald C., et al. "Understanding the Impact of Amyloid Beta Targeted Therapies on Biomarkers and Clinical Endpoints in Alzheimer's Disease." Alzheimer's & Dementia : Translational Research & Clinical Interventions 11, no. 2 (2025): e70069-n/a. https://doi.org/10.1002/trc2.70069.

MLA (9th ed.) Citation

Petersen, Ronald C., et al. "Understanding the Impact of Amyloid Beta Targeted Therapies on Biomarkers and Clinical Endpoints in Alzheimer's Disease." Alzheimer's & Dementia : Translational Research & Clinical Interventions, vol. 11, no. 2, 2025, pp. e70069-n/a, https://doi.org/10.1002/trc2.70069.